Dextromethorphan and guaifenesin use needs to be monitored carefully in sufferers with "bad metabolizer" CYP2D6 enzyme concentrations and sufferers who will be sedated. This mix medication includes a large median harmful dose (TD50) to median successful dose (ED50) ratio (or therapeutic index) in these patients. We only use excellent, credible https://chemicalglobe.com/product-tag/dxm-for-sale-near-me/